Daan Pieren

86 Chapter 3 24. Weeda, G. et al. Disruption of mouse ERCC1 results in a novel repair syndrome with growth failure, nuclear abnormalities and senescence . Curr. Biol. 7, 427-439, doi:10.1016/ s0960-9822(06)00190-4 (1997). 25. Johnson, S. C. et al. mTOR is a key modulator of ageing and age-related disease . Nature 493, 338-345, doi:10.1038/nature11861 (2013). 26. Bitto, A. et al. Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice . Elife 5, doi:10.7554/eLife.16351 (2016). 27. Harrison, D. E. et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice . Nature 460, 392-395, doi:10.1038/nature08221 (2009). 28. Chen, C. et al. mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells . Sci Signal 2, ra75, doi:10.1126/scisignal.2000559 (2009). 29. Hurez, V. et al. Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune-deficient mice . Aging Cell 14, 945-956, doi:10.1111/acel.12380 (2015). 30. Xie, X. et al. The mTOR-S6K pathway links growth signalling to DNA damage response by targeting RNF168 . Nat. Cell Biol. 20, 320-331, doi:10.1038/s41556-017-0033-8 (2018). 31. Shen, C. et al. The mTOR pathway negatively controls ATM by up-regulating miRNAs . Proc. Natl. Acad. Sci. U. S. A. 110, 11869-11874, doi:10.1073/pnas.1220898110 (2013). 32. Amir el, A. D. et al. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia . Nat. Biotechnol. 31, 545-552, doi:10.1038/ nbt.2594 (2013). 33. Duggal, N. A. et al. Can physical activity ameliorate immunosenescence and thereby reduce age-related multi-morbidity? Nat. Rev. Immunol. 19, 563-572, doi:10.1038/s41577- 019-0177-9 (2019). 34. Dai, H. et al. Cutting edge: programmed death-1 defines CD8+CD122+ T cells as regulatory versus memory T cells . J. Immunol. 185, 803-807, doi:10.4049/jimmunol.1000661 (2010). 35. Elizondo, D. M. et al. IL-10 producing CD8(+) CD122(+) PD-1(+) regulatory T cells are expanded by dendritic cells silenced for Allograft Inflammatory Factor-1 . J. Leukoc. Biol. 105, 123-130, doi:10.1002/JLB.1A0118-010RR (2019). 36. Miller, R. A. et al. Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction . Aging Cell 13, 468-477, doi:10.1111/ acel.12194 (2014). 37. Jiang, J. et al. Aging affects initiation and continuation of T cell proliferation . Mech. Ageing Dev. 128, 332-339, doi:10.1016/j.mad.2007.02.002 (2007). 38. Rodier, F. et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion . Nat. Cell Biol. 11, 973-979, doi:10.1038/ncb1909 (2009). 39. Pereira, B. I. et al. Senescent cells evade immune clearance via HLA-E-mediated NK and CD8(+) T cell inhibition . Nat Commun 10, 2387, doi:10.1038/s41467-019-10335-5 (2019). 40. Raynor, J. et al. IL-6 and ICOS Antagonize Bim and Promote Regulatory T Cell Accrual with Age . J. Immunol. 195, 944-952, doi:10.4049/jimmunol.1500443 (2015). 41. Karakasilioti, I. et al. DNA damage triggers a chronic autoinflammatory response, leading to fat depletion in NER progeria . Cell Metab. 18, 403-415, doi:10.1016/j.cmet.2013.08.011 (2013). 42. Chen, Q. et al. DNA damage drives accelerated bone aging via an NF-kappaB-dependent mechanism . J. Bone Miner. Res. 28, 1214-1228, doi:10.1002/jbmr.1851 (2013). 43. Kim, D. E. et al. Deficiency in the DNA repair protein ERCC1 triggers a link between senescence and apoptosis in human fibroblasts and mouse skin . Aging Cell 19, e13072, doi:10.1111/acel.13072 (2020). 44. Nakamura, Y. et al. Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling . Nature 369, 330-333, doi:10.1038/369330a0 (1994). 45. Liao, W. et al. Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy . Immunity 38, 13-25, doi:10.1016/j.immuni.2013.01.004 (2013). 46. Neff, F. et al. Rapamycin extends murine lifespan but has limited effects on aging . J. Clin. Invest. 123, 3272-3291, doi:10.1172/JCI67674 (2013). 47. Hori, S. et al. Control of regulatory T cell development by the transcription factor Foxp3 . Science 299, 1057-1061, doi:10.1126/science.1079490 (2003).